Clinical TrialsSearch results
Number of results: 2568
Other
- A phase I/II study of transarterial chemoembolization with cisplatin for hepatocellular carcinoma (JIVROSG-0401)
- Unresectable hypervascular hepatocellular carcinoma
- Japan Interventional Radiology in Oncology Study Group (JIVROSG)
- 2005-08-07
Other
- Cancer therapy with vaccination using HLA-A24-restricted peptide from URLC10:a phase I study in patient with unresectable esophageal cancer
- unresectable esophageal cancer
- Institute of Medical Science The University of Tokyo
- 2007-12-24
Other
- Cancer therapy with vaccination using HLA-A02 restricted peptide from human vascular endothelial growth factor receptor 2: a phase I study patients with unresectable colorectal cancer
- unresectable colorectal cancer
- Institute of Medical Science, University of Tokyo
- 2007-05-02
Other
- Cancer therapy with vaccination using HLA-A02-restricted peptide from RNF43: a phase I study in patients with unresectable colorectal cancer
- unresectable colorectal cancer
- Institute of Medical Science The University of Tokyo
- 2007-05-10
Other
- Cancer therapy with vaccination using HLA-A24-restricted peptide from human vascular endothelial growth factor receptor 2: a phase I study in patients with unresectable colorectal cancer
- unresectable colorectal cancer
- Institute of Medical Science, University of Tokyo
- 2007-05-02
Other
- Cancer therapy with vaccination using HLA-A24-restricted peptide from RNF43:a phase I study in patients with unresectable colorectal cancer
- unresectable colorectal cancer
- Institute of Medical Science, University of Tokyo
- 2007-05-07
Other
- Cancer therapy with vaccination using HLA-A24-restricted peptide from TOMM34:a phase I study in patients with unresectable colorectal cancer
- unresectable colorectal cancer
- Institute of Medical Science, University of Tokyo
- 2007-07-30
Other
- ONO-4578-02:ONO-4578 Phase 1 Study
- Unresectable colorectal cancer
- Hirashima Yoshinori
- 2020-11-25
Other
- Phase I clinical trial of epitope peptides based vaccines both targeting RNF43 and VEGFR2 in patients with advanced colorectal cancer.
- unresectable colorectal cancer
- Institute of Medical Science The University of Tokyo
- 2007-12-23
Recruiting
- A phase II study by using CICS-1 and SPM-011 commissioned by CICS and STELLA PHARMA
- Unresectable angiosarcoma
- Hayashi Toshimitsu
- 2022-10-26